These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 27894395

  • 1. Relationship between hepatitis B virus reverse transcriptase 181 mutation and S gene mutation in hepatitis B virus chronically infected patients.
    Wang LP, Han FZ, Yan XB, Fan YC, Wang K.
    Cell Mol Biol (Noisy-le-grand); 2016 Oct 31; 62(12):18-23. PubMed ID: 27894395
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus rtA181T/sW172non-stop mutation may increase resistance fold to adefovir- and entecavir-resistant mutants compared to rtA181T/sW172* mutation.
    Zhao L, Li X, Cheng Y, Chen R, Shao J, Zhou Y, Li Q, Liao H, Zhao Y, Liu L, Su H, Liu Y, Liu Y, Xu D.
    Antiviral Res; 2018 Jun 31; 154():26-34. PubMed ID: 29630974
    [Abstract] [Full Text] [Related]

  • 3. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
    Li X, Liu Y, Zhao P, Wang Y, Chen L, Xin S, Zhang XX, Xu D.
    Antivir Ther; 2015 Jun 31; 20(2):141-7. PubMed ID: 24992206
    [Abstract] [Full Text] [Related]

  • 4. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
    Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F.
    N Engl J Med; 2008 Dec 04; 359(23):2442-55. PubMed ID: 19052126
    [Abstract] [Full Text] [Related]

  • 5. rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy.
    Lee YS, Chung YH, Kim JA, Jin YJ, Park WH, Kim SE, Lee D, Shim JH, Kim KM, Lim YS, Lee HC, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2012 Feb 04; 27(2):300-5. PubMed ID: 21777282
    [Abstract] [Full Text] [Related]

  • 6. [Clinical analysis of hepatitis B virus mutations related to adefovir dipivoxil among patients with chronic hepatitis B virus infection in eastern Zhejiang province].
    Hu AR, Jiang SW, Li L, Ding SX, Hu YR, Liang XY.
    Zhonghua Yi Xue Za Zhi; 2012 Jul 17; 92(27):1878-81. PubMed ID: 23134956
    [Abstract] [Full Text] [Related]

  • 7. The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil.
    Liu Y, Li X, Xin S, Xu Z, Chen R, Yang J, Liu L, Wong VW, Yang D, Chan HL, Xu D.
    J Viral Hepat; 2015 Mar 17; 22(3):328-34. PubMed ID: 25132017
    [Abstract] [Full Text] [Related]

  • 8. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
    Osiowy C, Villeneuve JP, Heathcote EJ, Giles E, Borlang J.
    J Clin Microbiol; 2006 Jun 17; 44(6):1994-7. PubMed ID: 16757589
    [Abstract] [Full Text] [Related]

  • 9. [Dissection of mechanism for the adefovir dipivoxil resistance in chronic hepatitis B patients].
    Zeng AZ, Lu P, Deng H, Cai SF, Yang C, Xin XJ, Guo JJ, Li QL, Deng XH, Huang AL.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct 17; 17(10):730-4. PubMed ID: 19874686
    [Abstract] [Full Text] [Related]

  • 10. Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.
    Chen CH, Lee CM, Tung WC, Wang JH, Hung CH, Hu TH, Wang JC, Lu SN, Changchien CS.
    J Hepatol; 2010 Apr 17; 52(4):478-85. PubMed ID: 20185198
    [Abstract] [Full Text] [Related]

  • 11. Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates.
    Jiang SW, Yao LP, Hu AR, Hu YR, Chen SX, Xiong T, Gao GS, Liang XY, Ding SX, Weng PJ.
    World J Gastroenterol; 2014 Dec 07; 20(45):17100-6. PubMed ID: 25493022
    [Abstract] [Full Text] [Related]

  • 12. [The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection].
    Moon JH, Cho M, Yoon KT, Bae JH, Heo J, Kim GH, Kang DH, Song GA.
    Korean J Hepatol; 2008 Dec 07; 14(4):503-12. PubMed ID: 19119245
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations.
    Kim JH, Jung YK, Joo MK, Kim JH, Yim HJ, Park JJ, Kim JS, Bak YT, Yeon JE, Byun KS.
    J Korean Med Sci; 2010 Feb 07; 25(2):257-64. PubMed ID: 20119580
    [Abstract] [Full Text] [Related]

  • 18. Antiviral efficacy of entecavir for hepatitis B virus rtA181V/T mutants.
    Li P, Geng J, Li W, Xu X, Zhang X, Zheng W, Yu Y, Yang Z, Wang M.
    Virol J; 2017 Apr 04; 14(1):68. PubMed ID: 28376852
    [Abstract] [Full Text] [Related]

  • 19. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
    Neumann-Fraune M, Beggel B, Pfister H, Kaiser R, Verheyen J.
    J Med Virol; 2013 May 04; 85(5):775-9. PubMed ID: 23408582
    [Abstract] [Full Text] [Related]

  • 20. The impact of the hepatitis B virus polymerase rtA181T mutation on replication and drug resistance is potentially affected by overlapping changes in surface gene.
    Ahn SH, Park YK, Park ES, Kim JH, Kim DH, Lim KH, Jang MS, Choe WH, Ko SY, Sung IK, Kwon SY, Kim KH.
    J Virol; 2014 Jun 04; 88(12):6805-18. PubMed ID: 24696492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.